Adtalem Global Education (NYSE:CVSA) CEO Stephen Beard Sells 3,639 Shares of Stock

Adtalem Global Education Inc. (NYSE:CVSA) CEO Stephen Beard sold 3,639 shares of the business’s stock in a transaction on Thursday, October 8th. The shares were sold at an average price of $130.37, for a total transaction of $474,416.43. Following the transaction, the chief executive officer owned 473,825 shares of the company’s stock, valued at $61,772,565.25. This trade represents a 0.76% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Adtalem Global Education Trading Down 0.8%

Adtalem Global Education stock opened at $129.27 on Friday. The stock has a market cap of $4.38 billion, a P/E ratio of 18.36, a PEG ratio of 0.97 and a beta of 0.65. Adtalem Global Education Inc. has a fifty-two week low of $86.97 and a fifty-two week high of $156.26. The firm’s fifty day moving average price is $128.45 and its 200-day moving average price is $123.73. The company has a debt-to-equity ratio of 0.45, a quick ratio of 1.09 and a current ratio of 1.09.

Adtalem Global Education (NYSE:CVSA) last posted its earnings results on Thursday, August 6th. The company reported $2.09 EPS for the quarter, topping the consensus estimate of $1.90 by $0.19. The business had revenue of $501.38 million during the quarter. Adtalem Global Education had a return on equity of 20.88% and a net margin of 12.87%. Adtalem Global Education has set its FY 2027 guidance at 8.900-9.150 EPS. Equities research analysts forecast that Adtalem Global Education Inc. will post 9.00 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Adtalem Global Education

A hedge fund recently bought a new stake in Adtalem Global Education stock. Kendall Capital Management acquired a new position in Adtalem Global Education Inc. (NYSE:CVSA) in the second quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor acquired 11,622 shares of the company’s stock, valued at approximately $1,449,000. Institutional investors own 98.84% of the company’s stock.

Wall Street Analysts Forecast Growth

Several brokerages have recently commented on CVSA. BMO Capital Markets cut their price objective on Adtalem Global Education from $148.00 to $145.00 and set an “outperform” rating for the company in a report on Monday, October 5th. Wall Street Zen raised shares of Adtalem Global Education from a “hold” rating to a “buy” rating in a research note on Sunday, September 27th. Weiss Ratings cut shares of Adtalem Global Education from a “hold (c+)” rating to a “hold (c)” rating in a research note on Tuesday. Finally, Truist Financial cut shares of Adtalem Global Education from a “buy” rating to a “hold” rating and set a $140.00 price target for the company. in a research note on Thursday, September 3rd. Two research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to data from MarketBeat, the stock presently has an average rating of “Hold” and an average target price of $151.67.

Adtalem Global Education Company Profile

Adtalem Global Education is an education services company that provides professional, postsecondary and healthcare-focused education through institutions and brands serving students and working professionals. Its offerings include degree programs, career training, certification preparation and continuing education.

The company’s academic institutions include Chamberlain University, Walden University, American University of the Caribbean School of Medicine, Ross University School of Medicine, Ross University School of Veterinary Medicine and the Medical University of the Americas.